[go: up one dir, main page]

ZA926241B - Dosage form for delivering drug in short-time period - Google Patents

Dosage form for delivering drug in short-time period

Info

Publication number
ZA926241B
ZA926241B ZA926241A ZA926241A ZA926241B ZA 926241 B ZA926241 B ZA 926241B ZA 926241 A ZA926241 A ZA 926241A ZA 926241 A ZA926241 A ZA 926241A ZA 926241 B ZA926241 B ZA 926241B
Authority
ZA
South Africa
Prior art keywords
dosage form
short
time period
delivering drug
drug
Prior art date
Application number
ZA926241A
Other languages
English (en)
Inventor
George V Guittard
Howard A Carpenter
Ernest S Quan
Patrick S L Wong
Lawrence G Hamel
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of ZA926241B publication Critical patent/ZA926241B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA926241A 1991-08-19 1992-08-19 Dosage form for delivering drug in short-time period ZA926241B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/747,899 US5178867A (en) 1991-08-19 1991-08-19 Dosage form for delivering drug in short-time period

Publications (1)

Publication Number Publication Date
ZA926241B true ZA926241B (en) 1993-10-04

Family

ID=25007151

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA926241A ZA926241B (en) 1991-08-19 1992-08-19 Dosage form for delivering drug in short-time period

Country Status (17)

Country Link
US (1) US5178867A (xx)
EP (1) EP0600033B1 (xx)
JP (1) JP2934505B2 (xx)
AT (1) ATE129404T1 (xx)
AU (1) AU666674B2 (xx)
CA (1) CA2112679C (xx)
DE (1) DE69205687T2 (xx)
DK (1) DK0600033T3 (xx)
ES (1) ES2079206T3 (xx)
FI (1) FI940787A0 (xx)
GR (1) GR3017891T3 (xx)
MX (1) MX9204776A (xx)
NO (1) NO940376D0 (xx)
NZ (1) NZ244009A (xx)
PT (1) PT100789A (xx)
WO (1) WO1993003711A1 (xx)
ZA (1) ZA926241B (xx)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US5631023A (en) * 1993-07-09 1997-05-20 R.P. Scherer Corporation Method for making freeze dried drug dosage forms
US5523095A (en) * 1993-12-15 1996-06-04 Eastman Chemical Company Controlled release matrix system using cellulose acetate/polyvinylpyrrolidone blends
US5536505A (en) * 1993-12-15 1996-07-16 Eastman Chemical Company Controlled release matrix system using cellulose acetate/poly-2-ethyl-2-oxazoline blends
TW483763B (en) * 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
JP3463266B2 (ja) * 1995-09-21 2003-11-05 ファーマ パス エルエルシー 酸不安定性オメパラゾールを含有する新規組成物及びその製造方法
JP2001524131A (ja) * 1997-05-09 2001-11-27 セイジ、ファーマスーティカルズ、インク 安定な経口医薬品剤形
DE19747261A1 (de) * 1997-10-25 1999-04-29 Bayer Ag Osmotisches Arzneimittelfreisetzungssystem
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
ZA9810765B (en) * 1998-05-28 1999-08-06 Ranbaxy Lab Ltd Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole.
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
US7094426B2 (en) * 1998-08-27 2006-08-22 Sage Pharmaceuticals, Inc. Stable oral pharmaceutical dosage forms
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6099862A (en) 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
US6780880B1 (en) * 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6326384B1 (en) * 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
FR2797767B1 (fr) * 1999-08-27 2002-06-14 Centre Nat Rech Scient Utilisation d'acides amines pour la fabrication de medicaments destines au traitement des insulino-resistances
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
WO2001047498A2 (en) 1999-12-23 2001-07-05 Pfizer Products Inc. Hydrogel-driven layered drug dosage form comprising sertraline
US6669954B2 (en) 2000-01-25 2003-12-30 John R. Crison Controlled release of drugs
US6866866B1 (en) * 2000-11-03 2005-03-15 Andrx Labs, Llc Controlled release metformin compositions
US20060034922A1 (en) * 2000-11-03 2006-02-16 Andrx Labs, Llc Controlled release metformin compositions
EP1335708A4 (en) 2000-11-03 2005-07-13 Andrx Corp METFORMIN COMPOSITIONS WITH CONTROLLED RELEASE
US6790459B1 (en) 2000-11-03 2004-09-14 Andrx Labs, Llc Methods for treating diabetes via administration of controlled release metformin
AU2003241537A1 (en) * 2002-05-23 2003-12-12 Andrx Corporation Biguanide formulations
US20040005359A1 (en) * 2002-06-27 2004-01-08 Cheng Xiu Xiu Controlled release oral dosage form
JP4694841B2 (ja) 2002-09-20 2011-06-08 アンドルックス ラボズ リミテッド ライアビリティ カンパニー ビグアニドおよびチアゾリジンジオン誘導体を含有する多段階製剤
US20050051922A1 (en) * 2002-09-20 2005-03-10 Avinash Nangia Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
US20040166162A1 (en) * 2003-01-24 2004-08-26 Robert Niecestro Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid
TWI372066B (en) * 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US7051606B2 (en) * 2004-01-30 2006-05-30 Andrx Labs Llc Dosage form holder device and methods for immersion testing
CA2570916C (en) 2004-06-16 2013-06-11 Tap Pharmaceutical Products, Inc. Pulsed release dosage form of a ppi
US20050287185A1 (en) * 2004-06-23 2005-12-29 David Wong Extended release oxybutynin formulation
BRPI0609984A2 (pt) * 2005-05-25 2010-05-18 Transcept Pharmaceuticals Inc uso de zolpidem ou um sal do mesmo
US20070225322A1 (en) * 2005-05-25 2007-09-27 Transoral Pharmaceuticals, Inc. Compositions and methods for treating middle-of-the night insomnia
US20070287740A1 (en) * 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
DE102005031577A1 (de) 2005-07-06 2007-01-11 Bayer Healthcare Ag Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten
CA2629740A1 (en) * 2005-11-18 2007-06-14 Synthon B.V. Zolpidem tablets
EP2203068A4 (en) * 2007-10-12 2012-08-22 Takeda Pharmaceuticals Usa Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES INDEPENDENT FROM FOOD STORAGE
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
IN2014DN09045A (xx) 2012-05-07 2015-05-22 Bayer Pharma AG
DK4037666T3 (da) 2020-12-08 2024-06-24 Ruminant Biotech Corp Ltd Forbedring af anordninger og fremgangsmåder til indgivelse af substanser til dyr

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799241A (en) * 1949-01-21 1957-07-16 Wisconsin Alumni Res Found Means for applying coatings to tablets or the like
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4063064A (en) * 1976-02-23 1977-12-13 Coherent Radiation Apparatus for tracking moving workpiece by a laser beam
US4285987A (en) * 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4519801A (en) 1982-07-12 1985-05-28 Alza Corporation Osmotic device with wall comprising cellulose ether and permeability enhancer
US4576604A (en) * 1983-03-04 1986-03-18 Alza Corporation Osmotic system with instant drug availability
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4612008A (en) * 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4693895A (en) * 1984-10-26 1987-09-15 Alza Corporation Colon delivery system
US4608048A (en) * 1984-12-06 1986-08-26 Alza Corporation Dispensing device with drug delivery patterns
ES2019634B3 (es) * 1986-04-17 1991-07-01 Alza Corp Terapia con clorfeniramina.
US4948592A (en) * 1986-05-09 1990-08-14 Alza Corporation Pulsed drug delivery
US4801461A (en) * 1987-01-28 1989-01-31 Alza Corporation Pseudoephedrine dosage form
NZ226822A (en) * 1987-11-16 1990-03-27 Mcneil Consumer Prod Chewable medicament tablet containing means for taste masking
US4931285A (en) * 1988-04-28 1990-06-05 Alza Corporation Aqueous based pharmaceutical coating composition for dosage forms

Also Published As

Publication number Publication date
EP0600033A1 (en) 1994-06-08
MX9204776A (es) 1993-04-01
NZ244009A (en) 1995-02-24
AU666674B2 (en) 1996-02-22
NO940376L (no) 1994-02-07
FI940787L (fi) 1994-02-18
CA2112679A1 (en) 1993-03-04
WO1993003711A1 (en) 1993-03-04
ATE129404T1 (de) 1995-11-15
PT100789A (pt) 1994-05-31
AU2544992A (en) 1993-03-16
DK0600033T3 (da) 1995-12-27
FI940787A7 (fi) 1994-02-18
DE69205687T2 (de) 1996-04-11
JP2934505B2 (ja) 1999-08-16
DE69205687D1 (de) 1995-11-30
JPH06509809A (ja) 1994-11-02
NO940376D0 (no) 1994-02-07
CA2112679C (en) 2003-04-15
FI940787A0 (fi) 1994-02-18
EP0600033B1 (en) 1995-10-25
GR3017891T3 (en) 1996-01-31
US5178867A (en) 1993-01-12
ES2079206T3 (es) 1996-01-01

Similar Documents

Publication Publication Date Title
ZA926241B (en) Dosage form for delivering drug in short-time period
EP0494972A4 (en) Effervescent dosage form and method of administering same
GR3026674T3 (en) Dosage form for a delayed drug delivery.
WO1994027589A3 (en) Antidepressant dosage form
EP0745401A3 (en) Medication inhaler
GR3032207T3 (en) 2-Bromomelatonin in the therapy of sleep disorders
EP0552256A4 (xx)
DE69212879D1 (de) Magensaftstabile pharmazeutische Formulierungen zur Oral Verbreichung von Gallensäuren
EP0325843A3 (en) Pharmaceutical formulations for preventing drug tolerance
IL116993A0 (en) Extended-release solid oral dosage forms of drugs having low solubility in water
EP0279887A3 (en) Carnitine directed pharmaceutical agents and their use for the manufacture of a medicament for the treatment of muscle disorder
GR3035231T3 (en) Use of sulodexide and of medicines containing it for the treatment of diabetic nephropathy.
EP0438147A3 (en) Pharmaceutical compositions and dosage forms for the oral administration of calcitonin
ZA925146B (en) Pharmaceutical agent for treatment of withdrawal symptoms.
TW263437B (xx)
MY100780A (en) Azumolene dosage form.
IL88697A0 (en) Oral dosage units for pharmaceuticals and their use and preparation
FI930097A7 (fi) Annostusmuoto lääkeaineen antamiseksi vuorokausiterapian toteuttamista varten
EP0624368A3 (en) Use of a composition to stimulate glutathione synthesis for the manufacture of a medicament for the treatment of AID.
MD1609G2 (ro) Metodă de tratament al stomatitei aftoase recidivante cronice
IT1267664B1 (it) Composizione a base di fosfocreatina e suo uso farmaceutico
Češková et al. Alternative therapeutic approaches to the treatment of acute phases of endogenous psychoses.
IT1271354B (it) Preparazione di una forma farmaceutica atta a combattere l'iperinsulinismo contenente n-acetil cisteine e loro analoghi
IT1269412B (it) Apparecchio distributore di farmaci
ITMI912830A1 (it) Farmaco per uso umano ad azione oncostatica preventiva e terapeutica e ad azione neuro-immuno-stimolante